Caveolin and proteasome in tocotrienol mediated myocardial protection
about
Inhibitory effects of palm tocotrienol-rich fraction supplementation on bilirubin-metabolizing enzymes in hyperbilirubinemic adult ratsThe ubiquitin-proteasome system in myocardial ischaemia and preconditioning.Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases.The role of caveolae in endothelial cell dysfunction with a focus on nutrition and environmental toxicantsPharmacological potential of tocotrienols: a review.Gamma-tocotrienol induced apoptosis is associated with unfolded protein response in human breast cancer cellsWhy tocotrienols work better: insights into the in vitro anti-cancer mechanism of vitamin E.Caveolin as a potential drug target for cardiovascular protection.Comparative hepatoprotective effects of tocotrienol analogs against drug-induced liver injuryCo-ordinated autophagy with resveratrol and γ-tocotrienol confers synergetic cardioprotection.Modulation of microRNA 20b with resveratrol and longevinex is linked with their potent anti-angiogenic action in the ischaemic myocardium and synergestic effects of resveratrol and γ-tocotrienol.Caveolin-1/-3: therapeutic targets for myocardial ischemia/reperfusion injury.Multifaceted role of tocotrienols in cardioprotection supports their structure: function relation.Tocotrienol is a cardioprotective agent against ageing-associated cardiovascular disease and its associated morbidities.
P2860
Q28540018-5C3677F2-862D-465D-8F9C-412A60A729C1Q33554506-AA45224D-1FF4-44E6-992B-5EB001024251Q34209443-0F483B91-2D42-4896-9C65-498478EDB45DQ34247125-F3E1F0AB-0C54-4A5F-ADDA-058208D1C45DQ34450166-94C84510-8F70-4F39-AC1D-1B40118AD163Q35069549-478C6E89-5BBC-46F2-910C-D97D0CE73C76Q35648953-0D7C870B-FE13-4A2B-8F6C-80E0C7CBB20CQ36193737-7609F0C8-3D53-4995-9F84-1784D2B5F563Q36717800-6A99ACE2-8B4F-4B6D-9197-1ACEBA9B3CEEQ37295394-2D3D233A-D741-476B-8F1B-8C9A161597B3Q37296261-37BB933B-7E36-4BEF-B086-2B1F73384438Q38855645-DD555FE2-87DD-48F9-835D-06550F88C502Q40133052-A5C2A5BA-3817-49CD-A0EA-CE00EF81A61BQ48129928-09DAED28-F7E6-4325-8733-0278E83E6979
P2860
Caveolin and proteasome in tocotrienol mediated myocardial protection
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Caveolin and proteasome in tocotrienol mediated myocardial protection
@ast
Caveolin and proteasome in tocotrienol mediated myocardial protection
@en
Caveolin and proteasome in tocotrienol mediated myocardial protection
@nl
type
label
Caveolin and proteasome in tocotrienol mediated myocardial protection
@ast
Caveolin and proteasome in tocotrienol mediated myocardial protection
@en
Caveolin and proteasome in tocotrienol mediated myocardial protection
@nl
prefLabel
Caveolin and proteasome in tocotrienol mediated myocardial protection
@ast
Caveolin and proteasome in tocotrienol mediated myocardial protection
@en
Caveolin and proteasome in tocotrienol mediated myocardial protection
@nl
P2093
P2860
P356
P1476
Caveolin and proteasome in tocotrienol mediated myocardial protection
@en
P2093
Dipak K Das
Manika Das
Samarjit Das
Saul R Powell
P2860
P304
P356
10.1159/000149807
P577
2008-07-25T00:00:00Z